Gapping down
In reaction to disappointing earnings/guidance:
- HIVE -7.4%, JBHT -4%, OMC -0.8%
Other news:
- WVE -4.5% (announced the final results from its Phase 1 clinical trial of investigational suvodirsen in boys with Duchenne muscular dystrophy who are amenable to exon 51 skipping)
- JBGS -1.8% (prices underwritten public offering of 10 mln common shares at a public offering price of $42.00/share)
- WERN -0.8% (following JBHT earnings)
- FB -0.8% (CEO Mark Zuckerberg leveraged user data to compete with rivals, according to NBC News)
Analyst comments:
- SEMG -1.9% (downgraded to Underweight from Equal Weight at Barclays)
- MIC -1.5% (downgraded to Underweight from Equal Weight at Barclays)
- MLM -1.5% (downgraded to Underperform from Neutral at BofA/Merrill)
- GLP -1.4% (downgraded to Underweight from Equal Weight at Barclays)
- HFC -1.3% (downgraded to Neutral from Buy at MKM Partners)
- CTSH -1.1% (downgraded to Market Perform from Outperform at Wells Fargo)